OxySure Systems Inc. OXYS Archives - Page 2 of 3

TuesdayOct 15, 2013 9:14 am

OxySure Systems, Inc. (OXYS) Opens Larger Market Opportunity with Financing Service

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, reported the launch of OxySure Commercial Finance(SM), a service that enables easy and convenient lease of OxySure's suite of medical devices and products, including the OxySure Model 615, Automated External Defibrillators (AEDs), and other medical equipment, supplies and accessories. Powered by LeaseQ, OxySure’s new service allows customers to do comparison shopping for lease quotes from dozens of third party lenders with one simple online form that takes only two minutes to complete. The…

MondaySep 30, 2013 8:39 am

OxySure Systems, Inc. (OXYS) Demonstrates Growth through Positive Second Quarter Results

OxySure Systems is showing sure signs of progress and momentum, as demonstrated by its performance over the past few quarters and data released this week on this year’s second quarter earnings. On August 13, 2013, the company reported its second quarter financial results for the period ending on June 30. Total revenues were reported at $476,000, a 657% increase over the same period in 2012 and 98% sequentially from the first quarter of this year. Revenues consisted of $364,000 in products sales and $113,000 in revenues under licensing and service agreements. Operating expenses for the second quarter totaled $664,000, consisting…

ThursdaySep 26, 2013 10:28 am

OxySure Systems, Inc. (OXYS) to Exhibit Innovative Oxygen Technology at the Annual National Safety Council

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, will be an exhibitor at the National Safety Council's (NSC) 2013 Congress & Exposition, the world's largest annual event for safety, health, and environmental professionals. The event is taking place in Chicago from September 30 - October 2, 2013. NCS provides a way for OXYS to showcase its technology to Congress and expo attendees as members of the OXYS team will be discussing and providing demonstrations of its "oxygen from powder" technology and…

TuesdaySep 24, 2013 9:40 am

OxySure Systems, Inc. (OXYS) Provides Progress Update on CE Marking

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, this morning gave investors a progress report on the CE Marking of its flagship product, the OxySure Model 615. The company received notice earlier this month of an opinion rendered by the Medicines and Healthcare products Regulatory Authority (MHRA) in the United Kingdom related to the classification of the OxySure Model 615 as a medical device. An opinion of this nature by a competent authority is a key step in the CE Marking process. "We…

TuesdaySep 17, 2013 9:53 am

OxySure Systems, Inc. (OXYS) Kept with Buy Rating at Sterling Investment Services, PT Set at $1.90

Analysts at Sterling Investment Services today reiterated the Buy rating on medical technology company OxySure Systems. The firm set a 12-month price target of $1.90 on OXYS’ common stock. This is the third recently issued Buy rating on OXYS with a price target in the range of $1.75 to $2.10. OxySure focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered an FDA-approved solution to produce medically pure (USP) oxygen from inert powders for emergency and short duration use. The company owns several issued patents and patents pending on this technology, which makes the…

TuesdaySep 10, 2013 8:59 am

OxySure Systems, Inc. (OXYS) CEO Highlights Life Saving “Oxygen from Powder” Technology during Interview with The Stock Radio

OxySure Systems, a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today, was recently featured in an interview produced by The Stock Radio. Julian T. Ross, Chairman of the Board and CEO, discussed OxySure’s proprietary technology, the wide-spread application of this technology to save lives, and the company’s aggressive growth strategy and recent achievements. The interview is available at: http://thestockradio.com/julian-t-ross-chairman-ceo-of-oxysure-systems-inc-oxys-otcqb/2916 “This year we announced a very good milestone for us - a very exciting one…we’ve hit the 2,000 lives saved mark with this product.” Ross says in the interview. He also provides several…

FridaySep 06, 2013 10:36 am

OxySure Systems, Inc. (OXYS) Offers Superior Source of Emergency Oxygen

When an industry changing idea comes along, it isn’t long before people start to recognize its importance and wonder why it wasn’t developed earlier. Such is the case with OxySure Systems, inventors of a revolutionary way to supply oxygen for use in emergency situations, an approach that is safer, simpler to maintain, more affordable, and easier to use than conventional oxygen tanks. OxySure’s patented system is based upon two dry, inert, proprietary powders, which, when activated, produce medically pure oxygen. There are no compressed oxygen tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, no required…

TuesdayAug 27, 2013 8:41 am

Taglich Brothers Reiterates Buy Rating on OxySure Systems, Inc. (OXYS); Target Price $2.10 Per Share

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, was reiterated with a Speculative Buy rating from analysts at Taglich Brothers. Taglich Brothers set a 12-month price target of $2.10 on the stock. In the research update, Taglich Brothers also raised its revenue estimates for OXYS in anticipation of higher sales partially attributable to the company’s military business. The research firm expects sales to rise from $2 million in 2013 to $4.9 million in 2015. By 2017, revenues are projected to increase to $18…

TuesdayAug 20, 2013 8:48 am

QualityStocks Features OxySure Systems, Inc. (OXYS) CEO in Exclusive Interview

Today before the opening bell, QualityStocks announced that a new audio interview with OxySure Systems, Inc. is available. The interview can be heard at http://dtg.fm/OXYS-Interview-08-20. OXYS is a medical technology company that has pioneered a solution to produce medically pure oxygen from inert powders. The company's flagship product, the OxySure Model 615, is both safe and easy-to-use for the layperson. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by providing potentially life-saving oxygen in a medical emergency before the arrival of…

TuesdayAug 13, 2013 8:57 am

OxySure Systems, Inc. (OXYS) Triples Revenue for Second Consecutive Quarter

Today before the opening bell, OxySure reported its financial and operating results for the second quarter ended June 30, 2013. Second Quarter 2013 Highlights: Total revenue increased by about 657% to $476,071 General and administrative expense down by about 18% to $194,803 Interest expense down by about 60% to $23,254 Net loss declined by about 11.8% Working capital deficit improved by about $1,926,481 Stockholder deficit improved by about $2,359,951 Gross profit increased 758%; gross margins up to 68% from 60% Net loss per share for the quarter stayed flat at $.01 "We sustained positive momentum in the second quarter, and we are pleased…

Site Search

Company Search

Tag: OxySure Systems Inc. OXYS